Arquivos do dia: Janeiro 21, 2022
Opinião | A COVID-19 vai continuar, mas o fim da pandemia está próximo.
21 Jan, 2022 | 16:02hCOVID-19 will continue but the end of the pandemic is near – The Lancet
Comentário no Twitter
.@IHME_UW's Chris Murray predicting the end of the pandemic is nigh
"More than 50% of the world will have been infected with omicron …[by] the end of March, 2022"
"After the omicron wave, COVID-19 will return but the pandemic will not."https://t.co/9NSw8lZuUe @TheLancet— Eric Topol (@EricTopol) January 20, 2022
Opinião | Agora que a ciência já tornou a Covid menos grave, é hora de seguirmos com nossas vidas.
21 Jan, 2022 | 16:01hNow that science has defanged Covid, it’s time to get on with our lives – The Guardian
Ver também: A National Strategy for the “New Normal” of Life With COVID – JAMA
Europa considera uma nova estratégia contra COVID-19: aceitar o vírus.
21 Jan, 2022 | 16:00hEurope considers new COVID-19 strategy: Accepting the virus – Associated Press
Estudo randomizado | Imunogenicidade e reatogenicidade de diferentes vacinas de reforço após a primeira dose da vacina da J&J.
21 Jan, 2022 | 15:58h
Comentário no Twitter
Trial examined effects of boosting with one of the three approved #COVI19 vaccines — AD26.COV2.S, mRNA-1273, or BNT162b2 — 3 mos after the primary vaccination. All increased neutralizing-antibody levels & T-cell responses; mRNA vaccines were higher. https://t.co/qkpQFvNliJ pic.twitter.com/MUfa1OEsLP
— NEJM (@NEJM) January 19, 2022
Perspectiva | Consequências da COVID-19 para o sistema nervoso.
21 Jan, 2022 | 15:57hNervous system consequences of COVID-19 – Science
Conteúdos relacionados:
Review: Counting the neurological cost of COVID-19.
Neurological Effects of COVID-19 in Children.
International Registry: Ischemic and hemorrhagic stroke among critically ill patients with Covid-19.
Short review: Neurological complications of COVID-19.
2 new meta-analysis detail neurologic and psychiatric conditions in COVID-19.
M-A: Encephalitis as Neurological Complication of COVID‐19.
Large study finds 1 in 3 Covid-19 survivors have subsequent mental health and neurological conditionsEight out of ten people hospitalized with COVID-19 develop neurological problems – the most common self-reported symptoms included headache (37%) and anosmia or ageusia (26%).
Comentário no Twitter
A new #SciencePerspective discusses the neurological symptoms that accompany #COVID19 and the possible mechanisms that cause them. Read more: https://t.co/WKZpnWlbNc pic.twitter.com/U4ohecaVQd
— Science Magazine (@ScienceMagazine) January 20, 2022
Revisão | Avaliação pós-alta de indivíduos internados com COVID-19.
21 Jan, 2022 | 15:56hPostdischarge Evaluation for Individuals Hospitalized with COVID-19 – Southern Medical Journal
[Preprint] Gravidade da infecção por COVID em crianças com menos de 5 anos antes e depois do surgimento da variante Ômicron nos EUA.
21 Jan, 2022 | 15:54hComentário: SARS-CoV-2 Omicron infections milder in children compared to Delta – News Medical
Grupo de especialistas em emergências da OMS reafirma posição contra os “passaportes de vacina” para viagens internacionais.
21 Jan, 2022 | 15:53hEditorial | Vacinas contra Covid-19 e tratamentos: devemos ter os dados brutos, agora.
21 Jan, 2022 | 15:52hCovid-19 vaccines and treatments: we must have raw data, now – The BMJ
Comunicado de imprensa: Editors call for covid-19 vaccine and treatment data to be available for public scrutiny – The BMJ
Editorial | “Long covid” em crianças e adolescentes – “O risco parece baixo, mas muitas questões permanecem.”
21 Jan, 2022 | 15:51hLong covid in children and adolescents – The BMJ
Conteúdos relacionados:
Review: Long COVID symptoms in children rarely persist beyond three months.
Cohort study: Risk factors for long covid in previously hospitalized children.
M-A: More than 50 long-term effects of COVID-19.
Comentário no Twitter
"As SARS-CoV-2 remains predominantly a mild infection in the paediatric population, the incidence of long covid is a critical factor in the risk-benefit equation for policy and parental decisions on covid-19 vaccines for children," says Editorialhttps://t.co/POidCyS2RZ
— The BMJ (@bmj_latest) January 20, 2022